PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL

Clinical trial NCT04624984 · UNKNOWN

Trial details

NCT number: NCT04624984
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Classical Hodgkin Lymphoma Refractory or Relapsed Classical Hodgkin Lymphoma

Start date: 2021-04-01
Primary completion: 2025-04-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.